Search Results

postoperative radiation therapy (RT). However, predictors for recurrence after RT are not as clear. We analyzed our institutional experience with MSGTs to identify predictors of radiation outcomes. Methods: Ninety-one MSGT patients treated with adjuvant photon

• Distinguish the clinical presentations of the sporadic and familial forms of MTC • Describe the added value of external beam radiation therapy (EBRT) for patients with MTC • Identify options for the palliative treatment of MCT M

, there may be a bright future ahead for patients with H&N cancers and for the clinicians who treat them. Advances in radiation therapy (RT) have given Dr. Spencer and her colleagues some formidable tools to manage their patients with H&N cancers. “As we

, with a median survival time of 4 to 16 months, depending on the primary site. 4 – 6 Current treatment modalities available for the treatment of BMs are surgery, whole-brain radiation therapy (RT), and stereotactic radiosurgery (SRS). 7 , 8 The most

Cancer suggest consideration of radiation therapy (RT) with concurrent chemotherapy in larger T2 or T3 lesions not amenable to up-front organ-sparing surgery. 3 However, minimal published data, either retrospective or prospective, exists for patients

involving surgery, radiation oncology, medical oncology, radiology, and pathology. 2 NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for STS recommend the addition of neoadjuvant or adjuvant radiation therapy (RT) to surgery for patients

patients undergoing radiation therapy . Semin Oncol 2001 ; 28 ( suppl 8 ): 54 – 59 . 4 Irvine D Vincent L Graydon JE . The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy: A comparison

disease response rates are different after preoperative radiation therapy (RT) compared with chemotherapy is unclear—in other gastrointestinal malignancies, the use of preoperative RT is associated with higher pathologic response rates relative to

-C, cytarabine; CSF, cerebrospinal fluid; HBV, hepatitis B virus; HCT/ASCT, high-dose chemotherapy and autologous stem cell transplant; HCV, hepatitis C virus; MTX, methotrexate; WBRT, whole-brain radiation therapy. Once the diagnosis is confirmed, treatment must

prognosis in patients with RCC. 3 , 4 Even with these advances in systemic treatment, radiation therapy (RT) continues to play a significant role in managing patients with metastatic disease to the brain and spine. RT is used for palliation of painful bone